North America Sepsis Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Sepsis Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Sepsis Diagnostics Market Regional Analysis

6.2 North America Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)

6.3 North America Sepsis Diagnostics Market Forecast Analysis

7. North America Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments

7.1.1 Overview
7.1.2 Instruments: North America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Reagents and Assays

7.2.1 Overview
7.2.2 Reagents and Assays: North America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Blood Culture Media

7.3.1 Overview
7.3.2 Blood Culture Media: North America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Software

7.4.1 Overview
7.4.2 Software: North America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics

8.1.1 Overview
8.1.2 Molecular Diagnostics : North America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Sepsis Diagnostics Market Analysis – by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9. North America Sepsis Diagnostics Market Analysis – by Method

9.1 Automated Diagnostics and Conventional Diagnostics

9.1.1 Overview
9.1.2 Automated Diagnostics and Conventional Diagnostics: North America Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Sepsis Diagnostics Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Sepsis Diagnostics Market Breakdown, by Product
10.2.1.1.2 US: North America Sepsis Diagnostics Market Breakdown, by Technology
10.2.1.1.3 US: North America Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
10.2.1.1.4 US: North America Sepsis Diagnostics Market Breakdown, by Method

10.2.1.2 Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Sepsis Diagnostics Market Breakdown, by Product
10.2.1.2.2 Canada: North America Sepsis Diagnostics Market Breakdown, by Technology
10.2.1.2.3 Canada: North America Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
10.2.1.2.4 Canada: North America Sepsis Diagnostics Market Breakdown, by Method

10.2.1.3 Mexico : North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Sepsis Diagnostics Market Breakdown, by Product
10.2.1.3.2 Mexico : North America Sepsis Diagnostics Market Breakdown, by Technology
10.2.1.3.3 Mexico : North America Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
10.2.1.3.4 Mexico : North America Sepsis Diagnostics Market Breakdown, by Method

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 BD

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 bioMerieux SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Danaher (Beckman Coulter)

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 F. HOFFMANN-LA ROCHE LTD.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Immunexpress Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Luminex Corporation

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 T2 Biosystems, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 THERMO FISHER SCIENTIFIC INC.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Sepsis Diagnostics Market